Description: Glimnol MP-2 is a comprehensive formulation combining Glimepiride, Pioglitazone Hydrochloride, and Metformin Hydrochloride (Sustained Release) to effectively manage type 2 diabetes. This combination addresses multiple pathways in glucose control, offering a balanced approach to blood sugar regulation.
Key Benefits:Glimepiride: Stimulates insulin release from the pancreas, enhancing glucose controlPioglitazone Hydrochloride: Improves insulin sensitivity in muscle and fat tissues, reducing insulin resistanceMetformin Hydrochloride (Sustained Release): Provides extended glucose control by decreasing liver glucose production and improving insulin actionHelps maintain stable blood sugar levels and reduces the risk of diabetes-related complications
Composition:Glimepiride: Enhances insulin secretion to lower blood glucose levelsPioglitazone Hydrochloride: Increases the body sensitivity to insulinMetformin Hydrochloride (Sustained Release): Ensures prolonged and consistent blood glucose regulation
Recommended Usage:Take 1 tablet daily with food or as prescribed by your healthcare provider. Dosage may be adjusted based on individual blood glucose levels and therapeutic response.
Reviews
There are no reviews yet.